Wang S, Iyer R, Han X, Wei J, Li N, Cheng Y, et al. CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1-positive regulator for tumor immune evasion. J Clin Invest. 2023;133: pubmed publisher

Jacquier V, Gitenay D, Fritsch S, Bonnet S, Gyorffy B, Jalaguier S, et al. RIP140 inhibits glycolysis-dependent proliferation of breast cancer cells by regulating GLUT3 expression through transcriptional crosstalk between hypoxia induced factor and p53. Cell Mol Life Sci. 2022;79:270 pubmed publisher

Ivanova E, Sharma S, Brichkina A, Pfefferle P, Keber U, Pagenstecher A, et al. DYRK3 contributes to differentiation and hypoxic control in neuroblastoma. Biochem Biophys Res Commun. 2021;567:215-221 pubmed publisher

Riedl T, Faure Dupuy S, Rolland M, Schuehle S, Hizir Z, Calderazzo S, et al. HIF1α-mediated RelB/APOBEC3B downregulation allows Hepatitis B Virus persistence. Hepatology. 2021;: pubmed publisher

Kim H, Cho Y, Kim H, Kang D, Cheon D, Kim Y, et al. A system-level approach identifies HIF-2α as a critical regulator of chondrosarcoma progression. Nat Commun. 2020;11:5023 pubmed publisher

Yu J, Shi X, Yang C, Bullova P, Hong C, Nesvick C, et al. A novel germline gain-of-function HIF2A mutation in hepatocellular carcinoma with polycythemia. Aging (Albany NY). 2020;12:5781-5791 pubmed publisher

Yoo H, Park S, Nam M, Kang J, Kim K, Yeo J, et al. A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells. Cell Metab. 2019;: pubmed publisher

Soyal S, Bonova P, Kwik M, Zara G, Auer S, Scharler C, et al. The Expression of CNS-Specific PPARGC1A Transcripts Is Regulated by Hypoxia and a Variable GT Repeat Polymorphism. Mol Neurobiol. 2019;: pubmed publisher

Qi H, Wang S, Wu J, Yang S, Gray S, Ng C, et al. EGFR-AS1/HIF2A regulates the expression of FOXP3 to impact the cancer stemness of smoking-related non-small cell lung cancer. Ther Adv Med Oncol. 2019;11:1758835919855228 pubmed publisher

Faria M, Shepherd P, Pan Y, Chatterjee S, Navone N, Gustafsson J, et al. The estrogen receptor variants β2 and β5 induce stem cell characteristics and chemotherapy resistance in prostate cancer through activation of hypoxic signaling. Oncotarget. 2018;9:36273-36288 pubmed publisher

Senavirathna L, Huang C, Yang X, Munteanu M, Sathiaseelan R, Xu D, et al. Hypoxia induces pulmonary fibroblast proliferation through NFAT signaling. Sci Rep. 2018;8:2709 pubmed publisher

Diaz Trelles R, Scimia M, Bushway P, Tran D, Monosov A, Monosov E, et al. Notch-independent RBPJ controls angiogenesis in the adult heart. Nat Commun. 2016;7:12088 pubmed publisher

Zhuang Z, Yang C, Ryska A, Ji Y, Hou Y, Graybill S, et al. HIF2A gain-of-function mutations detected in duodenal gangliocytic paraganglioma. Endocr Relat Cancer. 2016;23:L13-6 pubmed publisher

Imagawa K, de Andrés M, Hashimoto K, Itoi E, Otero M, Roach H, et al. Association of reduced type IX collagen gene expression in human osteoarthritic chondrocytes with epigenetic silencing by DNA hypermethylation. Arthritis Rheumatol. 2014;66:3040-51 pubmed publisher

Zhu J, Jiang X, Chehab F. FoxO4 interacts with the sterol regulatory factor SREBP2 and the hypoxia inducible factor HIF2? at the CYP51 promoter. J Lipid Res. 2014;55:431-42 pubmed publisher

Guan Z, Ding C, Du Y, Zhang K, Zhu J, Zhang T, et al. HAF drives the switch of HIF-1α to HIF-2α by activating the NF-κB pathway, leading to malignant behavior of T24 bladder cancer cells. Int J Oncol. 2014;44:393-402 pubmed publisher

Yang C, Sun M, Matro J, Huynh T, Rahimpour S, Prchal J, et al. Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas. Blood. 2013;121:2563-6 pubmed publisher

Kondo K, Klco J, Nakamura E, Lechpammer M, Kaelin W. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell. 2002;1:237-46 pubmed